Life science product company Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line. The line is designed to ...
Bio-Rad Laboratories (NYSE:BIO) shares fell 9.5% to $253.48 on Thursday after the life sciences company cut its 2026 revenue forecast and reported first-quarter results that missed analyst ...
Thank you, Regina. My name is Ruben Argueta, Bio-Rad's new Head of IR. Today, we will review the financial results for the first quarter ended March 31, 2026, and provide an update on key business ...
Performance was significantly impacted by the Middle East conflict, a region representing over 9% of Diagnostics revenue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results